Literature DB >> 21090935

Role of vitamin D in arterial hypertension.

Stefan Pilz1, Andreas Tomaschitz.   

Abstract

Vitamin D deficiency is highly prevalent and may contribute to arterial hypertension. The antihypertensive effects of vitamin D include suppression of renin and parathyroid hormone levels and renoprotective, anti-inflammatory and vasculoprotective properties. Low 25-hydroxyvitamin D levels, which are used to classify the vitamin D status, are an independent risk factor for incident arterial hypertension. Meta-analyses of randomized controlled trials showed that vitamin D supplementation reduces systolic blood pressure by 2-6 mmHg. However, further studies are needed before drawing a final conclusion on the effect of vitamin D therapy on blood pressure and cardiovascular risk. In our current clinical practice we should take into account the high prevalence of vitamin D deficiency, the easy, cheap and safe way by which it can be supplemented and the promising clinical data suggesting that vitamin D might be useful for the treatment of arterial hypertension as well as other chronic diseases. Therefore, we recommend that testing for and treating vitamin D deficiency in patients with arterial hypertension should be seriously considered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21090935     DOI: 10.1586/erc.10.142

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  17 in total

1.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

Review 2.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

3.  Raynaud's phenomenon and vitamin D.

Authors:  Josiane Hélou; Roy Moutran; Ismael Maatouk; Fady Haddad
Journal:  Rheumatol Int       Date:  2012-05-12       Impact factor: 2.631

4.  Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy.

Authors:  Vania B Rezende; Valeria C Sandrim; Ana C Palei; Lorena Machado; Ricardo C Cavalli; Geraldo Duarte; Jose E Tanus-Santos
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

5.  Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study.

Authors:  Lu Yao; Aaron R Folsom; James S Pankow; Elizabeth Selvin; Erin D Michos; Alvaro Alonso; Weihong Tang; Pamela L Lutsey
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

6.  Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial.

Authors:  Sakineh Shab-Bidar; Tirang R Neyestani; Abolghassem Djazayery; Mohammad-Reza Eshraghian; Anahita Houshiarrad; A'azam Gharavi; Ali Kalayi; Nastaran Shariatzadeh; Malihe Zahedirad; Niloufar Khalaji; Homa Haidari
Journal:  BMC Med       Date:  2011-11-24       Impact factor: 8.775

7.  25-Hydroxy vitamin D levels and endothelial vasodilator function in normotensive women.

Authors:  Sibel Ertek; Ebru Akgül; Arrigo F Cicero; Utku Kütük; Selda Demirtaş; Sengül Cehreli; Gürbüz Erdoğan
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

8.  A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum.

Authors:  Robert P Heaney; Christine B French; Stacie Nguyen; Mia Ferreira; Leo L Baggerly; Ludovic Brunel; Paul Veugelers
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

Review 9.  Vitamin D and cardiovascular disease.

Authors:  Katharina Kienreich; Andreas Tomaschitz; Nicolas Verheyen; Thomas Pieber; Martin Gaksch; Martin R Grübler; Stefan Pilz
Journal:  Nutrients       Date:  2013-07-31       Impact factor: 5.717

10.  Poststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention.

Authors:  Alexander Fisher; Wichat Srikusalanukul; Michael Davis; Paul Smith
Journal:  Stroke Res Treat       Date:  2013-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.